Neuralink's Breakthrough: First Human Results in Prestigious Medical Journal
Neuralink, the brain-computer interface company founded by Elon Musk, has submitted a scientific paper to the prestigious New England Journal of Medicine. Michael Lawton, CEO of the Barrow Neurological Institute, has confirmed this development.
The paper, authored by Neuralink's team, presents results from the first three patients who received the company's brain implants. This marks a significant step forward for Neuralink, which has previously reported implanting its devices in twelve people worldwide. The paper is expected to provide detailed insights into the safety and efficacy of the Neuralink devices in human patients.
While the specific authors of the paper are not yet known, the submission to such a renowned journal indicates that the results are robust and scientifically sound. The paper is anticipated to shed light on the potential of brain-computer interfaces to treat neurological disorders and enhance human capabilities.
Neuralink's submission of a scientific paper to the New England Journal of Medicine signals a major milestone in the company's quest to develop safe and effective brain-computer interfaces. The paper, detailing results from the first three patients, is set to provide valuable insights into the potential of this groundbreaking technology.
Read also:
- U.S. Army Europe & Africa Bolsters Regional Security with Enhanced Partnerships & Deterrence
- BMW's Debrecen Plant Unveiled: Birthplace of the iX3 and New Class Models
- Mapbox's Navigation Software Development Kit integrated with MapGT's Artificial Intelligence Voice Assistant
- US President Trump and UK Labour Leader Starmer discuss strengthening economic and technological ties between the United States and the United Kingdom.
